Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Yoshikatsu Kaneko,*
Falk Nimmerjahn,*
Jeffrey V. Ravetch
Abstract:
Immunoglobulin G (IgG) mediates pro- and anti-inflammatory activitiesthrough the engagement of its Fc fragment (Fc) with distinctFcg receptors (FcgRs). One class of Fc-FcgR interactions generatespro-inflammatory effects of immune complexes and cytotoxic antibodies.In contrast, therapeutic intravenous gamma globulin and itsFc fragments are anti-inflammatory. We show here that thesedistinct properties of the IgG Fc result from differential sialylationof the Fc core polysaccharide. IgG acquires anti-inflammatoryproperties upon Fc sialylation, which is reduced upon the inductionof an antigen-specific immune response. This differential sialylationmay provide a switch from innate anti-inflammatory activityin the steady state to generating adaptive pro-inflammatoryeffects upon antigenic challenge.
Laboratory of Molecular Genetics and Immunology, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA.
* These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: ravetch{at}rockefeller.edu
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Dennis R. Burton and Raymond A. Dwek (4 August 2006) Science313 (5787), 627.
[DOI: 10.1126/science.1131712] |Summary »|Full Text »|PDF »
Sialic acid content of tissue-specific gp96 and its potential role in modulating gp96-macrophage interactions.
R. Suriano, S. K Ghosh, D. Chaudhuri, A. Mittelman, A. Banerjee, and R. K Tiwari (2009)
Glycobiology
19, 1427-1435
|Abstract »|Full Text »|PDF »
The Inhibitory Fc{gamma}IIb Receptor Dampens TLR4-Mediated Immune Responses and Is Selectively Up-regulated on Dendritic Cells from Rheumatoid Arthritis Patients with Quiescent Disease.
M. H. Wenink, K. C. M. Santegoets, M. F. Roelofs, R. Huijbens, H. J. P. M. Koenen, R. van Beek, I. Joosten, F. Meyer-Wentrup, L. Mathsson, J. Ronnelid, et al. (2009)
J. Immunol.
183, 4509-4520
|Abstract »|Full Text »|PDF »
Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside.
G Zandman-Goddard, M Blank, and Y Shoenfeld (2009)
Lupus
18, 884-888
|Abstract »|PDF »
Glycosylation profiles of epitope-specific anti-{beta}-amyloid antibodies revealed by liquid chromatography-mass spectrometry.
I. Perdivara, L. J Deterding, C. Cozma, K. B Tomer, and M. Przybylski (2009)
Glycobiology
19, 958-970
|Abstract »|Full Text »|PDF »
Nonredundant Roles for B Cell-Derived IL-10 in Immune Counter-Regulation.
R. Madan, F. Demircik, S. Surianarayanan, J. L. Allen, S. Divanovic, A. Trompette, N. Yogev, Y. Gu, M. Khodoun, D. Hildeman, et al. (2009)
J. Immunol.
183, 2312-2320
|Abstract »|Full Text »|PDF »
Impaired inhibitory Fc{gamma} receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy.
B. Tackenberg, I. Jelcic, A. Baerenwaldt, W. H. Oertel, N. Sommer, F. Nimmerjahn, and J. D. Lunemann (2009)
PNAS
106, 4788-4792
|Abstract »|Full Text »|PDF »
Reply to Bayry et al.: The anti-inflammatory activity of sialylated IgG Fcs.
J. Ravetch, R. Anthony, F. Wermeling, and M. Karlsson (2009)
PNAS
106, E25
|Full Text »|PDF »
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag.
P. Wu, W. Shui, B. L. Carlson, N. Hu, D. Rabuka, J. Lee, and C. R. Bertozzi (2009)
PNAS
106, 3000-3005
|Abstract »|Full Text »|PDF »
A Mechanism of Sialylation Functionally Silences the Hyaluronan Receptor LYVE-1 in Lymphatic Endothelium.
T. D. Nightingale, M. E. F. Frayne, S. Clasper, S. Banerji, and D. G. Jackson (2009)
J. Biol. Chem.
284, 3935-3945
|Abstract »|Full Text »|PDF »
Memory Alloreactive B Cells and Alloantibodies Prevent Anti-CD154-Mediated Allograft Acceptance.
A. M. Burns, L. Ma, Y. Li, D. Yin, J. Shen, J. Xu, and A. S. Chong (2009)
J. Immunol.
182, 1314-1324
|Abstract »|Full Text »|PDF »
Macrophages Activated by C-Reactive Protein through Fc{gamma}RI Transfer Suppression of Immune Thrombocytopenia.
K. D. Marjon, L. L. Marnell, C. Mold, and T. W. Du Clos (2009)
J. Immunol.
182, 1397-1403
|Abstract »|Full Text »|PDF »
Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors.
S. L. Sazinsky, R. G. Ott, N. W. Silver, B. Tidor, J. V. Ravetch, and K. D. Wittrup (2008)
PNAS
105, 20167-20172
|Abstract »|Full Text »|PDF »
Inaugural Article: Identification of a receptor required for the anti-inflammatory activity of IVIG.
R. M. Anthony, F. Wermeling, M. C. I. Karlsson, and J. V. Ravetch (2008)
PNAS
105, 19571-19578
|Abstract »|Full Text »|PDF »
Sialic Acid Residues Are Essential for the Anaphylactic Activity of Murine IgG1 Antibodies.
S. R. Silva, A. Casabuono, J. F. Jacysyn, B. C. Favoretto, I. Fernandes, M. S. Macedo, A. S. Couto, and E. L. Faquim-Mauro (2008)
J. Immunol.
181, 8308-8314
|Abstract »|Full Text »|PDF »
Improved Tumor Immunity Using Anti-Tyrosinase Related Protein-1 Monoclonal Antibody Combined with DNA Vaccines in Murine Melanoma.
Y. M. Saenger, Y. Li, K. C. Chiou, B. Chan, G. Rizzuto, S. L. Terzulli, T. Merghoub, A. N. Houghton, and J. D. Wolchok (2008)
Cancer Res.
68, 9884-9891
|Abstract »|Full Text »|PDF »
Crucial Role of Aspartic Acid at Position 265 in the CH2 Domain for Murine IgG2a and IgG2b Fc-Associated Effector Functions.
L. Baudino, Y. Shinohara, F. Nimmerjahn, J.-I. Furukawa, M. Nakata, E. Martinez-Soria, F. Petry, J. V. Ravetch, S.-I. Nishimura, and S. Izui (2008)
J. Immunol.
181, 6664-6669
|Abstract »|Full Text »|PDF »
The Golgi CMP-sialic acid transporter: A new CHO mutant provides functional insights.
S. F. Lim, M. M. Lee, P. Zhang, and Z. Song (2008)
Glycobiology
18, 851-860
|Abstract »|Full Text »|PDF »
Proteolytic Shedding of ST6Gal-I by BACE1 Regulates the Glycosylation and Function of {alpha}4{beta}1 Integrins.
A. V. Woodard-Grice, A. C. McBrayer, J. K. Wakefield, Y. Zhuo, and S. L. Bellis (2008)
J. Biol. Chem.
283, 26364-26373
|Abstract »|Full Text »|PDF »
Impact of a Three Amino Acid Deletion in the CH2 Domain of Murine IgG1 on Fc-Associated Effector Functions.
L. Baudino, F. Nimmerjahn, Y. Shinohara, J.-I. Furukawa, F. Petry, J. S. Verbeek, S.-I. Nishimura, J. V. Ravetch, and S. Izui (2008)
J. Immunol.
181, 4107-4112
|Abstract »|Full Text »|PDF »
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells.
M. Peipp, J. J. Lammerts van Bueren, T. Schneider-Merck, W. W. K. Bleeker, M. Dechant, T. Beyer, R. Repp, P. H. C. van Berkel, T. Vink, J. G. J. van de Winkel, et al. (2008)
Blood
112, 2390-2399
|Abstract »|Full Text »|PDF »
Review: New advances in the treatment of neurological diseases using high dose intravenous immunoglobulins.
M. Stangel (2008)
Therapeutic Advances in Neurological Disorders
1, 115-124
|Abstract »|PDF »
Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions.
E. A. Hod, C. M. Cadwell, J. S. Liepkalns, J. C. Zimring, S. A. Sokol, D. A. Schirmer, J. Jhang, and S. L. Spitalnik (2008)
Blood
112, 891-894
|Abstract »|Full Text »|PDF »
The Antiinflammatory IgG.
S. V. Kaveri, S. Lacroix-Desmazes, and J. Bayry (2008)
N. Engl. J. Med.
359, 307-309
|Full Text »|PDF »
Response of Dystrophic Calcification to Intravenous Immunoglobulin.
S. Schanz, A. Ulmer, and G. Fierlbeck (2008)
Arch Dermatol
144, 585-587
|Full Text »|PDF »
Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc.
R. M. Anthony, F. Nimmerjahn, D. J. Ashline, V. N. Reinhold, J. C. Paulson, and J. V. Ravetch (2008)
Science
320, 373-376
|Abstract »|Full Text »|PDF »
From the Cover: IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions.
C. N. Scanlan, D. R. Burton, and R. A. Dwek (2008)
PNAS
105, 4081-4082
|Full Text »|PDF »
Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis.
A. S. Mehta, R. E. Long, M. A. Comunale, M. Wang, L. Rodemich, J. Krakover, R. Philip, J. A. Marrero, R. A. Dwek, and T. M. Block (2008)
J. Virol.
82, 1259-1270
|Abstract »|Full Text »|PDF »
Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.
A. Ephrem, S. Chamat, C. Miquel, S. Fisson, L. Mouthon, G. Caligiuri, S. Delignat, S. Elluru, J. Bayry, S. Lacroix-Desmazes, et al. (2008)
Blood
111, 715-722
|Abstract »|Full Text »|PDF »
Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion.
J. Chang, P. A. Shi, E. Y. Chiang, and P. S. Frenette (2008)
Blood
111, 915-923
|Abstract »|Full Text »|PDF »
Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool.
O. Hershkovitz, M. Jarahian, A. Zilka, A. Bar-Ilan, G. Landau, S. Jivov, Y. Tekoah, R. Glicklis, J. T. Gallagher, S. C. Hoffmann, et al. (2008)
Glycobiology
18, 28-41
|Abstract »|Full Text »|PDF »
Ovarian Cancer is Associated with Changes in Glycosylation in Both Acute-Phase Proteins and IgG.
R. Saldova, L. Royle, C. M Radcliffe, U. M Abd Hamid, R. Evans, J. N Arnold, R. E Banks, R. Hutson, D. J Harvey, R. Antrobus, et al. (2007)
Glycobiology
17, 1344-1356
|Abstract »|Full Text »|PDF »
Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange.
M. van der Neut Kolfschoten, J. Schuurman, M. Losen, W. K. Bleeker, P. Martinez-Martinez, E. Vermeulen, T. H. den Bleker, L. Wiegman, T. Vink, L. A. Aarden, et al. (2007)
Science
317, 1554-1557
|Abstract »|Full Text »|PDF »
Depletion of B Cells in Murine Lupus: Efficacy and Resistance.
A. Ahuja, J. Shupe, R. Dunn, M. Kashgarian, M. R. Kehry, and M. J. Shlomchik (2007)
J. Immunol.
179, 3351-3361
|Abstract »|Full Text »|PDF »
A Mechanistic Perspective of Monoclonal Antibodies in Cancer Therapy Beyond Target-Related Effects.
S. E. Strome, E. A. Sausville, and D. Mann (2007)
Oncologist
12, 1084-1095
|Abstract »|Full Text »|PDF »
Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures.
M. Sack, A. Paetz, R. Kunert, M. Bomble, F. Hesse, G. Stiegler, R. Fischer, H. Katinger, E. Stoeger, and T. Rademacher (2007)
FASEB J
21, 1655-1664
|Abstract »|Full Text »|PDF »
The Neutralization Properties of a HIV-Specific Antibody Are Markedly Altered by Glycosylation Events Outside the Antigen-Binding Domain.
L. R. Miranda, M. Duval, H. Doherty, M. S. Seaman, M. R. Posner, and L. A. Cavacini (2007)
J. Immunol.
178, 7132-7138
|Abstract »|Full Text »|PDF »
Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.
F. Nimmerjahn, R. M. Anthony, and J. V. Ravetch (2007)
PNAS
104, 8433-8437
|Abstract »|Full Text »|PDF »
Sialylated therapeutic IgG: a sweet remedy for inflammatory diseases?.
J. D. Dimitrov, J. Bayry, S. Siberil, and S. V. Kaveri (2007)
Nephrol. Dial. Transplant.
22, 1301-1304
|Full Text »|PDF »
Sialic Acid on Herpes Simplex Virus Type 1 Envelope Glycoproteins Is Required for Efficient Infection of Cells.
M. P. Wise, A. Gallimore, A. Godkin, C. A.L.S. Colaco, A. Sharpe, and A. Abbas (2006)
N. Engl. J. Med.
355, 2594-2595
|Full Text »|PDF »
N-Linked Glycosylation of Folded Proteins by the Bacterial Oligosaccharyltransferase..
M. Kowarik, S. Numao, M. F. Feldman, B. L. Schulz, N. Callewaert, E. Kiermaier, I. Catrein, and M. Aebi (2006)
Science
314, 1148-1150
|Abstract »|Full Text »|PDF »